
Samsung’s Galaxy Watch 6 to Introduce FDA-Approved Heart-Rate Monitoring Feature
Samsung announced today that the IHRN (Irregular Heart Rhythm Notification) component of the existing ECG (Electrocardiogram) feature on Galaxy Watches received FDA clearance. Galaxy Watch users will soon be able to use the BioActive Sensor on their Wear OS wearables to look for signs of atrial fibrillation (AFib). Samsung says the FDA-cleared IHRN feature will…